Market Access in the Era of Specialty & Biotech – An EBI Virtual Conference in Partnership with inVentiv Health

The call for real-world evidence is the “shot heard round the world” in this new decade of global healthcare. Skyrocketing healthcare costs, an unraveling state of global finance and unprecedented technological advances in medicine have both commercial and government payers looking for answers to what seems to be an age-old question: How do we reduce costs while improving quality?

By understanding market access considerations during development, companies can design the right protocols, create a label to achieve superior reimbursement and coverage, better leverage evidence developed during the clinical stage, and eliminate access hurdles by demonstrating value.

Elsevier Business Intelligence invites you to Market Access in the Era of Specialty & Biotech – An EBI Virtual Conference, in partnership with inVentiv Health. On December 13, attendees will hear insights from market access and regulatory thought leaders at inVentiv Patient Access Solutions, Health Policy Strategies, Prevision Policy, ParagonRx, PharmaNet/i3, and Campbell Alliance. Gather information on tactics and best practices from experts at ZIOPHARM Oncology, Shire and Novo Nordisk. Learn what payers and government policymakers are focused on in the coming years, with representation from inVentiv Medical Management, Mayo Clinic, MedMetrics and the Agency for Healthcare Research and Quality. 

You and your entire team will have the ability to listen to this live, interactive training session from your office, conference room or home. Experts will spend 50-minutes focused on specific topics and tools with a 15-minute Q&A session after each.

Prepare your team and register today!

December 13, 2011
Time: 10:00 am – 4:30pm ET
Duration: 6 hours & 30 minutes

Leave a Reply

Your email address will not be published. Required fields are marked *